EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings ...

Novo Nordisk has taken the bold step of buying three manufacturing facilities from contract development and manufacturing organisation Catalent ... doing in active pharmaceutical ingredients ...